A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

NCT03254784 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Arthritic Psoriasis
Psoriasis
Inflammatory Bowel Diseases

Interventions

DRUG: BMS-986165 Capsule
DRUG: BMS-986165 Tablet

Sponsor

Bristol-Myers Squibb